We are analyzing https://link.springer.com/chapter/10.1007/978-1-4613-1247-5_4.

Title:
Peritoneal-plasma barrier | SpringerLink
Description:
Intraperitoneal chemotherapy has been described as a therapeutic option in the management of a variety of malignancies that occur primarily in a locoregional manner [1]. Potential benefits of this technique may occur in tumors principally confined to the peritoneal...
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, peritoneal, cas, pubmed, intraperitoneal, sugarbaker, article, cancer, chemotherapy, chapter, carcinomatosis, management, transport, privacy, cookies, content, publish, research, access, clin, dialysis, rat, data, information, search, treatment, malignancies, cavity, gastrointestinal, preview, oncol, fluid, log, journal, principles, peritonealplasma, barrier, jacquet, drug, download, early, postoperative, absorption, ther, boston, springer, optional, analysis, personal,

Topics {✒️}

enteric serosal surface peritoneal-plasma barrier combination intraperitoneal chemotherapy peritonea-plasma barrier privacy choices/manage cookies chapter peritoneal carcinomatosis intraperitoneal 5-fluorouracil diminish download preview pdf malignancies principally confiend peritoneal dialysis efficiency peritoneal-plasma transport chapter cite med clin north european economic area tumors principally confined transperitoneal exchange iv physiopathologie du péritoine macro-molecules studied ceftizoxime elimination kinetics loco-regional naure intraperitoneal chemotherapy journal finder publish conditions privacy policy human peritoneal fluid scanning electron microscopy intraperitoneally administered compounds de cruijn ea prolonged treatment schedules accepting optional cookies chapter jacquet book series refractoy ovarian carcinoma peritoneal access sugarbaker ph main content log transperitoneal fluid transport dedrick rl peritoneal dialysis check access ethics access chapter log intraperitoneal drug peritoneal carcinomatosis gastrointestinal malignancies academic press schultz js permissions reprints journal publish privacy policy personal data

Schema {🗺️}

ScholarlyArticle:
      headline:Peritoneal-plasma barrier
      pageEnd:63
      pageStart:53
      image:https://media.springernature.com/w153/springer-static/cover/book/978-1-4613-1247-5.jpg
      genre:
         Medicine
         Medicine (R0)
      isPartOf:
         name:Peritoneal Carcinomatosis: Principles of Management
         isbn:
            978-1-4613-1247-5
            978-1-4612-8531-1
         type:Book
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Pierre Jacquet
            affiliation:
            type:Person
            name:Paul H. Sugarbaker
            affiliation:
            type:Person
      keywords:Peritoneal Cavity, Peritoneal Carcinomatosis, Mesothelial Cell, Peritoneal Fluid, Continuous Ambulatory Peritoneal Dialysis
      description:Intraperitoneal chemotherapy has been described as a therapeutic option in the management of a variety of malignancies that occur primarily in a locoregional manner [1]. Potential benefits of this technique may occur in tumors principally confined to the peritoneal cavity (gastrointestinal malignancies and ovarian carcinoma) [2,3]. Theoretically, the use of intraperitoneal drug could eliminate local tumor spread as a mechanism of cancer recurrence both in the abdomen and in the pelvis.
      datePublished:1996
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Peritoneal Carcinomatosis: Principles of Management
      isbn:
         978-1-4613-1247-5
         978-1-4612-8531-1
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Pierre Jacquet
      affiliation:
      name:Paul H. Sugarbaker
      affiliation:
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(85)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js

4.82s.

LINK . SPRINGER . COM {}